Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: A retrospective cohort study

European Journal of Endocrinology

Volumn 169, Issue 3, 2013, Pages 367-376

  Bogazzi, Fausto ^a   Colao, Annamaria ^b   Rossi, Giuseppe ^c   Lombardi, Martina ^a   Urbani, Claudio ^a   Sardella, Chiara ^a   Iannelli, Aldo ^a   Scattina, Ilaria ^a   Manetti, Luca ^a   Del Sarto, Simone ^c   Pivonello, Rosario ^b   Francesca, Ludovica ^a   Grasso, Stella ^b   Lupi, Isabella ^a   Auriemma, Renata Simona ^b   Lombardi, Gaetano ^b   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; GROWTH HORMONE; HYPOPHYSIS HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ACUTE HEART INFARCTION; ADENOMA; ADULT; AGE; ARTERIAL PRESSURE; ARTICLE; BILE DUCT CANCER; BREAST CANCER; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COLON CARCINOMA; COLONOSCOPY; COMBINATION CHEMOTHERAPY; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; HEART FAILURE; HIGH RISK PATIENT; HORMONE DEFICIENCY; HUMAN; HYPOADRENALISM; HYPOGONADISM; HYPOPHYSECTOMY; HYPOPHYSIS TUMOR; HYPOPITUITARISM; HYPOTHYROIDISM; INTERMETHOD COMPARISON; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MICROADENOMA; MONOTHERAPY; MORTALITY; MULTIVARIATE ANALYSIS; PHYSICAL CAPACITY; PITUITARY ADENOMECTOMY; PITUITARY HORMONE DEFICIENCY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADIOTHERAPY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SEX; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; UNIVARIATE ANALYSIS; UTERUS CANCER;

ACROMEGALY; ADULT; COHORT STUDIES; COMBINED MODALITY THERAPY; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHYSECTOMY; ITALY; MALE; MEDICAL RECORDS; MIDDLE AGED; MORTALITY; PITUITARY GLAND; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SOMATOSTATIN; SURVIVAL ANALYSIS;

EID: 84883426727     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0166     Document Type: Article

References (32)

1. Kauppinen-Makelin R, Sane T, Reunanen A, Valimaki MJ, Niskanen L, Markkanen H, Loyttyniemi E, Ebeling T, Jaatinen P, Laine H et al. A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2005 90 4081-4086. (doi:10.1210/jc.2004-1381)
2. Colao A, Ferone D, Marzullo P & Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. EndocrineReviews 2004 25 102-152. (doi:10.1210/er.2002-0022)
3. Holdaway IM, Rajasoorya CR, Gamble GD & Stewart AW. Longterm treatment outcome in acromegaly. Growth Hormone & IGF Research 2003 13 185-192. (doi:10.1016/S1096-6374(03) 00030-3)
4. Melmed S. Acromegaly pathogenesis and treatment. Journal of Clinical Investigation 2009 119 3189-3202. (doi:10.1172/JCI39375)
5. Wright AD, Hill DM, Lowy C & Fraser TR. Mortality in acromegaly. Quarterly Journal of Medicine 1970 39 1-16.
6. Alexander L, Appleton D, Hall R, Ross WM & Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clinical Endocrinology 1980 12 71-79. (doi:10.1111/j.1365-2265.1980. tb03135.x)
7. Bengtsson BA, Eden S, Ernest I, Oden A & Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Medica Scandinavica 1988 223 327-335. (doi:10.1111/j.0954-6820. 1988.tb15881.x)
8. Rajasoorya C, Holdaway IM,Wrightson P, Scott DJ & Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology 1994 41 95-102. (doi:10.1111/j.1365-2265.1994.tb03789.x)
9. Orme SM, McNally RJ, Cartwright RA & Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 1998 83 2730-2734. (doi:10.1210/jc.83.8.2730)
10. Swearingen B, Barker FG II, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM & Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism 1998 83 3419-3426. (doi:10.1210/jc.83.10. 3419)
11. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM & Bates AS. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 1613-1617. (doi:10.1210/jc.2003-031584)
12. Biermasz NR, Dekker FW, Pereira AM, van Thiel SW, Schutte PJ, van Dulken H, Romijn JA & Roelfsema F. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. Journal of Clinical Endocrinology and Metabolism 2004 89 2789-2796. (doi:10.1210/jc.2003-032041)
13. Holdaway IM, Rajasoorya RC & Gamble GD. Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 667-674. (doi:10.1210/jc.2003-031199)
14. Holdaway IM, Bolland MJ & Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology 2008 159 89-95. (doi:10.1530/EJE-08-0267)
15. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA & Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2008 93 61-67. (doi:10.1210/jc.2007-1191)
16. Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS & Stewart PM. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2009 94 4216-4223. (doi:10.1210/jc.2009-1097)
17. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001 357 425-431. (doi:10.1016/S0140-6736(00)04006-X)
18. Colao A & Ghigo E. The manifesto A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) study group one year later: what to keep and what to amend? Journal of Endocrinological Investigation 2007 30 903-906.
19. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J et al. Guidelines for acromegaly management: an update. Journal of Clinical Endocrinology and Metabolism 2009 94 1509-1517. (doi:10.1210/jc.2008-2421)
20. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K & Melmed S. A consensus on criteria for cure of acromegaly. Journal of Clinical Endocrinology and Metabolism 2010 95 3141-3148. (doi:10.1210/jc.2009-2670)
21. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension 2007 25 1105-1187. (doi:10.1097/HJH.0b013e3281fc975a)
22. Alberti KG & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 539-553. (doi:10.1002/(SICI)1096-9136(199807)15:7!539::AID-DIA668 O3.0.CO;2-S)
23. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143-3421.
24. Mak PH, Campbell RC & Irwin MG. The ASA physical status classification: inter-observer consistency. Anaesthesia and Intensive Care 2002 30 633-640.
25. Wolters U, Wolf T, Stutzer H & Schroder T. ASA classification and perioperative variables as predictors of postoperative outcome. British Journal of Anaesthesia 1996 77 217-222. (doi:10.1093/bja/77.2.217)
26. Breslow NE & Day NE. Statistical methods in cancer research. In The Analysis of Case-control Studies, Vol 1, pp 5-338. Lyon, France: IARC Scientific Publications, 1980.
27. Breslow NE & Day NE. Statistical methods in cancer research. In The Design and Analysis of Cohort Studies, Vol 2, pp 1-406. Lyon, France: IARC Scientific Publications, 1987.
28. Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. European Journal of Endocrinology 2012 167 189-198. (doi:10.1530/EJE-12-0084)
29. Bihan H, Espinosa C, Valdes-Socin H, Salenave S, Young J, Levasseur S, Assayag P, Beckers A & Chanson P. Longterm outcome of patients with acromegaly and congestive heart failure. Journal of Clinical Endocrinology and Metabolism 2004 89 5308-5313. (doi:10.1210/jc.2004-0821)
30. Petersenn S, Buchfelder M, Reincke M, Strasburger CM, Franz H, Lohmann R, Quabbe HJ & Plockinger U. Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. European Journal of Endocrinology 2008 159 525-532. (doi:10.1530/EJE-08-0498)
31. Neggers SJ, Kopchick JJ, Jorgensen JOL & van der Lely AJ. Hypothesis: extra-hepatic acromegaly: a new paradigm? European Journal of Endocrinology 2011 164 11-16. (doi:10.1530/EJE-10-0969)
32. Rubeck KZ, Madsen M, Andreasen CM, Fisker S, Frystyk J & Jørgensen JOL. Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery. European Journal of Endocrinology 2010 163 717-722. (doi:10.1530/EJE-10-0640)